A synthetic version of low molecular weight heparin is poised for clinical trials and development as a drug for patients with clotting disorders, and those undergoing procedures such as kidney dialysis, heart bypass surgery, stent implantation, and knee and hip replacement.
from Diet and Weight Loss News -- ScienceDaily http://ift.tt/2vMOPmZ
No comments:
Post a Comment